Order Article Reprints

Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics. 2021; 11(1):98. https://doi.org/10.3390/diagnostics11010098

Ballestri, Stefano, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, and Amedeo Lonardo. 2021. "Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease" Diagnostics 11, no. 1: 98. https://doi.org/10.3390/diagnostics11010098

Ballestri, S., Mantovani, A., Baldelli, E., Lugari, S., Maurantonio, M., Nascimbeni, F., Marrazzo, A., Romagnoli, D., Targher, G., & Lonardo, A. (2021). Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics, 11(1), 98. https://doi.org/10.3390/diagnostics11010098